NCT04741295

Low Molecular Weight Heparin on the Adenomyosis Patients'IVF-ET Outcome

To Study the Effect of Low Molecular Weight Heparin on the Adenomyosis Patients'Outcome of in Vitro Fertilization-embryo Transplantation

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 70 (estimated)
• Sponsor: Nanjing University · Academic / Other
• Sex: Female
• Age: 20 Years – 38 Years
• Healthy volunteers: Not accepted

Summary

In assisted reproductive technology, adenomyosis patients are characterized by lower clinical pregnancy rate, lower implantation rate and higher abortion rate. The purpose of this study is to explore whether low molecular weight heparin can reduce the abortion rate of adenomyosis patients in frozen thawed embryo transfer cycles.

Conditions

• Adenomyosis
• Assisted Reproductive Technology

Interventions

Type	Name	Description
DRUG	Low molecular weight heparin	Patients with adenomyosis were treated with low molecular weight heparin after frozen embryo transfer in addition to routine luteal support.

Timeline

• Start date: 2020-02-01
• Primary completion: 2022-01-31
• Completion: 2022-01-31
• First posted: 2021-02-05
• Last updated: 2021-02-05

Locations

1 site across 1 country: China